Skip to main content

Table 2 Comparison of IFN-γ releasing assay (IGRA) results in patients with active and inactive SLE

From: Decreased ex vivo production of interferon-gamma is associated with severity and poor prognosis in patients with lupus

Variables

Active SLE (n = 64)

Inactive SLE (n = 54)

p value

IGRA results, n (%)

 Positive

4 (6.2)

9 (16.6)

0.073

 Negative

31 (48.4)

45 (83.3)

<0.001

 Indeterminate

29 (45.3)

0 (0.0)

<0.001

IFN-γ level (IU/mL)

 Nil (IU/mL)

0.45 (2.00)

0.09 (0.05)

<0.001

 Tuberculosis antigen (IU/mL)

0.43 (1.61)

0.12 (0.21)

0.028

 Mitogen (IU/mL)

2.93 (7.09)

11.15 (5.03)

<0.001

 Ex vivo IFN-γ production (IU/mL)a

0.92 (4.93)

11.06 (5.27)

<0.001

  1. Values are expressed as the median (interquartile range) or number (percentage)
  2. IFN-γ interferon gamma, IGRA IFN-γ-releasing assay
  3. aEx vivo IFN-γ production was estimated by calculating the difference in IFN-γ production between the mitogen tube and the nil tube (mitogen minus nil)